FDA.reportPublic FDA data

Tadliq 4 MG/ML Oral Suspension

RxCUI
2613569
RxNorm name
Tadliq 4 MG/ML Oral Suspension
Display name
Tadliq 4 MG/ML Oral Suspension
Full name
Tadliq 4 MG/ML Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TADLIQTADALAFILCMP Pharma, Inc.7a909b25-3772-403e-a5fe-e4a040293fb72022-10-15Warnings, Adverse reactionsExact identifier
rxcui: 2613569

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7a909b25-3772-403e-a5fe-e4a040293fb7tadliq 20 MG in 5 mL Oral Suspension [PSN] · tadalafil 4 MG/ML Oral Suspension [Tadliq] [SBD] · Tadliq 20 MG per 5 mL Oral Suspension [SY] · Tadliq 4 MG/ML Oral Suspension [SY]46These highlights do not include all the information needed to use TADLIQ safely and effectively. See full prescribing information for TADLIQ. TADLIQ ® (tadalafil) oral suspension Initial U.S. Approval: 200320221015